John A. Stalfort III - 10 Jun 2024 Form 4 Insider Report for Acumen Pharmaceuticals, Inc. (ABOS)

Role
Director
Signature
/s/ Derek Meisner, Attorney-in-Fact
Issuer symbol
ABOS
Transactions as of
10 Jun 2024
Transactions value $
$0
Form type
4
Filing time
10 Jun 2024, 16:49:05 UTC
Previous filing
31 May 2024
Next filing
26 Nov 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABOS Stock Option (right to buy) Award $0 +25K $0.00 25K 10 Jun 2024 Common Stock 25K $2.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest on the earlier of June 10, 2025 or the 2025 annual stockholder meeting, subject to the Reporting Person's continuous service through each such vesting date.